The broader goals of the proposed work are aimed at the development of chemical approaches to the study of cell division and ultimately cancer. More specifically, the developing field of 'chemical genetics' will be applied to the understanding of cell cycle regulators and the mitotic spindle checkpoint. The King laboratory has identified several compounds that block exit from mitosis and inhibit cyclin proteolysis. The goals of the proposed research are to identify the biochemical targets of these compounds and pursue the mechanism of how these compounds inhibit cyclin proteolysis. Additionally, we propose to develop a new strategy that will enable the rapid identification of protein targets of active compounds found in chemical genetic screens.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32GM068276-01
Application #
6649050
Study Section
Special Emphasis Panel (ZRG1-F05 (20))
Program Officer
Wolfe, Paul B
Project Start
2003-04-01
Project End
2006-03-31
Budget Start
2003-04-01
Budget End
2004-03-31
Support Year
1
Fiscal Year
2003
Total Cost
$41,608
Indirect Cost
Name
Harvard University
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
082359691
City
Cambridge
State
MA
Country
United States
Zip Code
02138
Tochtrop, Gregory P; King, Randall W (2004) Target identification strategies in chemical genetics. Comb Chem High Throughput Screen 7:677-88
Verma, Rati; Peters, Noel R; D'Onofrio, Mariapina et al. (2004) Ubistatins inhibit proteasome-dependent degradation by binding the ubiquitin chain. Science 306:117-20